We are live on ! Find out more
RAIN

Rain Oncology Inc. Common Stock

Delisted

RAIN was delisted on the 25th of January, 2024.

40 hedge funds and large institutions have $233M invested in Rain Oncology Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ZP
26
Zimmer Partners
New York
$155K +$175K +10,000 New
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$98K +$110K +6,300 New
LFM
28
Lumina Fund Management
New York
$93K +$105K +6,000 New
Deutsche Bank
29
Deutsche Bank
Germany
$68K +$77.2K +4,405 New
JP Morgan Chase
30
JP Morgan Chase
New York
$44K +$49.9K +2,849 New
ASN
31
Advisory Services Network
Georgia
$36K +$40.3K +2,300 New
SO
32
STRS Ohio
Ohio
$26K +$29.8K +1,700 New
Bank of America
33
Bank of America
North Carolina
$18K +$20K +1,140 New
TRCT
34
Tower Research Capital (TRC)
New York
$15K +$16.6K +950 New
Legal & General Group
35
Legal & General Group
United Kingdom
$11K +$12.5K +714 New
Citigroup
36
Citigroup
New York
$10K +$11.6K +660 New
AIP
37
Ameritas Investment Partners
Nebraska
$9K +$10.2K +582 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$9K +$10.6K +603 New
Morgan Stanley
39
Morgan Stanley
New York
$5K +$6.89K +393 New
AIG
40
American International Group
New York
$65 +$72.9K +4,158 New

RAIN Hedge Fund Activity: Q2 2021 in Review

40 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q2 2021, worth a combined $233M.

Buyers outnumbered sellers: 40 funds opened new RAIN positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $46M.

  • 40 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $233M of Rain Oncology Inc. Common Stock stock for Q2 2021.
  • 40 funds opened new Rain Oncology Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +40 holders.
  • The largest Rain Oncology Inc. Common Stock buyer in Q2 2021 was Cormorant Asset Management, an estimated $46M added.

Based on aggregated 13F filings for Q2 2021.